Aug. 29, 2024
The U.S. Food and Drug Administration (FDA) this week provided notice of final guidance issued by the Center for Devices and Radiological Health, Mammography Quality Standards Act (MQSA) and Regulation Amendments: Small Entity Compliance Guide (SECG). The FDA developed the SECG to explain the actions a small entity must take to comply with the MQSA rule and its implementing regulations.

The March 2023 MQSA rule modernized mammography regulations and specifies that the mammography report given to patients specifies if they have dense or non-dense breast tissue; it includes a prescribed paragraph on the significance of breast density.

The FDA prepared the SECG to help small entities comply with MQSA regulation changes, which take effect Sept. 10.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.

Related ACR News

  • Supreme Court Upholds Preventive Services Coverage

    ACR commends the Supreme Court’s ruling affirming the constitutionality of the structure and appointment process of the U.S. Preventive Services Task Force.

    Read more
  • ACR Drives Urgency For Medicare Pay Fix in Senate Bill

    ACR highlighted the urgent need for a permanent Medicare physician pay fix in a June 23 letter to U.S. Senate leaders.

    Read more
  • ACR Urges Senate to Reconsider Student Loan Program Changes

    ACR and other medical groups cautioned that the student loan provisions would make medical and dental education less accessible to many qualified individuals.

    Read more